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Abstract 
Background: Pain management can be challenging during root canal treatment of teeth with 
irreversible pulpitis. 
Aim: To identify whether articaine or lidocaine is the most appropriate local anaesthetic 
solution for teeth with irreversible pulpitis undergoing root canal treatment.  
Data source: The protocol of this umbrella review is registered in the PROSPERO database 
(CRD42019137624). PubMed, EBSCHO host and Scopus databases were searched until June 
2019.  
Study eligibility criteria, participants, and interventions: Systematic reviews published 
in English comparing the effectiveness of local anaesthesia following administration of 
articaine or lidocaine in patients undergoing root canal treatment of teeth diagnosed with 
irreversible pulpitis were included. Two independent reviewers selected the studies, carried 
out the data extraction and the appraisal of the included reviews. Disagreements were 
resolved in consultation with a third reviewer. 
Study appraisal and synthesis methods: The quality of the included reviews was 
appraised by two independent reviewers using the AMSTAR tool (A measurement tool to 
assess systematic reviews). Each of the 11 AMSTAR items, was given a score of 1 if the 
specific criterion was met, or 0 if the criterion was not met or the information was unclear. 
Results: Five systematic reviews with meta-analyses were included. The AMSTAR score for 
the reviews ranged from 8-11, out of a maximum score of 11, and all reviews were categorized as high  quality. Two reviews scored 0 for item 8 in AMSTAR because the 
scientific quality of the clinical trials included in these reviews was not used in the 
formulation of the conclusions.  
 
Limitations:  Systematic reviews published only in English language were included. Only a 
small number of studies were available to assess pain intensity during the injection phase, 
the time until the onset of anaesthesia and the occurrence of adverse events.   
Conclusions and implications of key findings: Articaine is more effective than lidocaine 
for local anaesthesia of teeth with irreversible pulpitis undergoing root canal treatment.  
There is limited evidence that injection of articaine is less painful, has more rapid onset and 
has fewer adverse events compared with lidocaine.   
Declaration of interest:  No funding was obtained for the conduct of this review. The authors 
declare no conflict of interest. 
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systematic review 
 
 
 
 
 
 
 
 
 
 
Introduction 
Adequate pain management is essential to ensure patient comfort and reduce fear and 
anxiety during dental treatment (Scott et al. 1982, Khan et al. 2016). Achieving profound 
anaesthesia during root canal treatment is often challenging, particularly in teeth with 
symptomatic irreversible pulpitis (Modaresi et al. 2006, Segura-Egea et al. 2009). This may 
be attributed to a range of factors, central sensitization including, prostaglandin-induced 
sensitization of peripheral nociceptors, acute tachyphylaxis, inflammatory responses 
affecting local tissue pH and blood flow, and psychological factors (Hargreaves & Keiser 
2004, Henry & Hargreaves 2007, Khann et al. 2007, Owatz et al. 2007).   
 
Lidocaine (or lignocaine) is the most commonly used local anaesthetic solution in 
dentistry (Gaffen & Haas 2009, Oliver et al. 2016).  Chemically classed as an amide 
anaesthetic, lidocaine has a rapid onset of action and an intermediate duration of anaesthesia 
when combined with adrenaline. It is generally accepted that this combination has the ability 
to produce pulpal anaesthesia for approximately 60 minutes and soft tissue anaesthesia for 
3–5 hours (Malamed 2006, Kung et al. 2015). Articaine is another amide local anaesthetic 
solution that substitutes a thiophene ring for the benzene ring present in lidocaine. This 
modification allows articaine molecules to diffuse through nerve membranes more 
effectively than lidocaine molecules, due to increased lipid solubility. The two solutions 
further differ by the incorporation of an ester linkage into the articaine molecule, which 
results in hydrolysis of articaine by plasma esterases (Malamed et al. 2001). Ninety to 95% 
of articaine is metabolized in the blood by plasma esterases, with the remainder being 
broken down in the liver, whereas 90% of lidocaine is metabolized in the liver (Oertel et al. 
1997, Brandt et al. 2011). 
 
Several randomised clinical trials have reported that articaine is more effective than 
lidocaine in achieving profound dental pulp anaesthesia particularly following infiltration in 
the maxilla (Evans et al. 2008, Srinivasan et al. 2009) and as a supplementary infiltration 
following inferior alveolar nerve block (IANB) in the mandible (Aggarwal et al. 2009, Ashraf 
et al. 2013, Rogers et al. 2014). Conversely, other clinical trials have reported no benefit of 
articaine over lidocaine for pulpal anaesthesia in irreversibly pulpitic mandibular teeth after 
IANB (Tortamano et al. 2009, Aggarwal et al. 2017).  
 
In an attempt to better understand the inconsistent results of these randomised 
clinical trials, several systematic reviews and meta-analyses comparing the efficacy of 
articaine and lidocaine have been published. The first systematic review comparing articaine 
with lidocaine (Katyal 2010) concluded that articaine was more effective than lidocaine for 
successful local anaesthesia during routine dentistry following infiltration in the first 
maxillary molar region and after IANB in the mandibular molar region. However, this 
systematic review included teeth with a range of pulpal diagnoses and did not select 
specifically for irreversible pulpitis. Another review (Brandt et al. 2011) compared the 
anaesthetic efficacy of lidocaine with articaine for pulpal anaesthesia in maxillary and 
mandibular posterior teeth, after infiltration or block routes of administration respectively. 
It concluded that while there was no difference in efficacy between articaine and lidocaine it 
was too early to recommend articaine for mandibular block anaesthesia for teeth with 
irreversible pulpitis (Brandt et al. 2011). Since then, four additional systematic reviews have 
concluded that articaine is superior to lidocaine for pulpal anaesthesia, at least by some 
routes of administration, for teeth with irreversible pulpitis (Kung et al. 2015, Su et al. 2016, 
St George et al. 2018, Nagendrababu et al. 2019).  The review by Kung et al. (2015) analysed 
studies on infiltration and block anaesthetic techniques separately and concluded that there 
was no difference in the efficacy of articaine and lidocaine for mandibular block or maxillary 
infiltration, with the only benefit of articaine being for supplementary infiltrations in 
mandibular teeth. The more recent reviews reported that articaine was superior to lidocaine 
for pulpal anaesthesia following IANB during treatment of mandibular posterior teeth with 
irreversible pulpitis in both children (Su et al. 2016) and adults (Nagendrababu et al. 2019), 
whereas the review by St George et al. (2018) reported that there was no evidence of a 
difference between the anaesthetic solutions.  
 An umbrella  review represents an overview of systematic reviews and is a new 
approach to analyse a collection of systematic reviews on a defined topic or question.  An 
umbrella review should identify both the strengths and shortcomings of existing systematic 
reviews that could affect the quality of the results obtained.  Such reviews also help to 
identify consistent or contradictory findings when considering whether the independent 
systematic reviews assessed the question and arrived at reliable conclusions (Aromataris et 
al. 2015, 2017).     
 
This umbrella review was undertaken to analyse the results of previous systematic 
reviews in order to determine: 
1. The most effective local anaesthetic solution for teeth with irreversible pulpitis when 
comparing articaine and lidocaine;  
2. The anaesthetic solution associated with the least pain during injection when comparing 
articaine and lidocaine; 
3. The anaesthetic solution with the most rapid onset of pulpal anaesthesia when 
comparing articaine and lidocaine;  
4. The anaesthetic solution with the fewest adverse events when comparing articaine and 
lidocaine; and 
5. Reporting deficiencies and gaps in knowledge in this area.  
 
Methods 
This current umbrella review was developed according to the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) guidelines (Moher et al. 2019). The 
protocol of the review was registered in the PROSPERO database (CRD42019137624 ).  
 
Review questions 
The review questions were developed based on the PICO (population, intervention, control, 
and outcome) framework:  
1. Is articaine (I) more effective than lidocaine (C) for dental pulp anaesthesia (O) in 
maxillary and mandibular teeth with irreversible pulpitis undergoing root canal treatment 
(P)?  
2. Does articaine (I) result in more rapid onset of pulpal anaesthesia (O) than lidocaine (C) 
in maxillary and mandibular teeth with irreversible pulpitis undergoing root canal treatment 
(P)?  
3. Does the injection of articaine (I) cause less pain (O) than the injection of lidocaine (C) in 
patients (P) with irreversibly pulpitic maxillary and mandibular teeth undergoing root canal 
treatment?  
4. Does articaine (I) result in fewer adverse events (O) than lidocaine (C) following 
administration in the maxilla and mandible for root canal treatment of patients (P) with 
irreversible pulpitis?  
 
Selection criteria 
Articles were included if they satisfied the following criteria:  
• systematic reviews with or without meta-analysis; 
• published in English; 
• reviews comparing anaesthetic efficacy between articaine and lidocaine/lignocaine 
in patients undergoing root canal treatment in maxillary and/or mandibular teeth 
with irreversible pulpitis.   
Narrative reviews, case reports and individual clinical trials were excluded.   
 
Data source and search strategy 
The literature search was performed in PubMed, EBSCOhost and Scopus electronic 
databases from inception to June 2019 using the following search strategy: (((((articaine) 
OR lidocaine) OR lignocaine)) AND ((((((((root canal) OR endod) OR irreversible pulpitis) 
OR inferior alveolar nerve block) OR Gow-Gates) OR mental incisive nerve block) OR 
Vazirani-Akinosi) OR maxillary infiltration)) AND ((systematic review) OR meta-analysis). 
Reference lists of included systematic reviews were also hand searched to identify other 
relevant systematic reviews.  Initially, two independent reviewers (VN, SP) screened the 
titles and abstracts of identified reviews to decide on inclusion or exclusion. In cases of doubt 
after reading the title and abstract, the full-text of each systematic review was read to decide 
on their inclusion/exclusion. Disagreements were resolved with the help of a third reviewer 
(PD). If needed, the authors of included reviews were contacted to provide missing data 
and/or clarify information that was unclear.  
 
Data extraction 
Two independent reviewers (NV, SP) performed the data extraction. Disagreements were 
resolved by consulting with the third reviewer (PD).  Two separate data extraction forms 
were created: 
i) General characteristics of the included systematic reviews and meta-analyses: name and 
country of the first author, year of publication, name of the journal published, database 
searched, search period during which the original included studies were published, 
languages included, interventions, number of studies included for meta-analysis, number of 
participants, type of study design included, instrument used to assess the quality of included 
studies and outcome assessed; 
ii) Summary of the meta-analyses: meta-analysis model, number of samples in intervention 
and comparison group (total and events), study-specific relative risk estimates (risk ratio, 
odds ratio, or standardized mean differences) along with the corresponding 95% confidence 
intervals (CI), I2 statistic and publication bias. 
 
 
 
Primary outcome 
Successful pulpal anaesthesia in maxillary and mandibular teeth with irreversible pulpitis 
undergoing root canal treatment.  The diagnostic criteria for irreversible pulpitis were: 
moderate to severe spontaneous pain, prolonged response to a cold test and a positive 
response to an electric pulp test.  Anaesthetic success was defined as: no pain or mild pain 
according to patient-reported pain scores during access cavity preparation and 
instrumentation or no response to pulp sensibility testing (heat/cold/electric pulp tester).  
 
Secondary outcomes 
1. Pain intensity during local anaesthetic injection, 2. Time of onset of pulpal anaesthesia, 
and 3. Adverse events reported. 
 
Methodological quality assessment  
Two independent reviewers (VN, SP) appraised the methodological quality of included 
systematic reviews using the AMSTAR tool (A measurement tool to assess systematic 
reviews) (Shea et al. 2007). A third reviewer (PD) resolved doubts or discrepancies between 
the two reviewers. The AMSTAR checklist consists of 11 items. Each item was given a score 
of 1 if the specific criterion was met, or 0 if the criterion was not met or information was 
unclear. Missing information was obtained by contacting the authors; if there was no 
response the item was scored as 0.  After scoring, each systematic review was categorised 
into high, medium and low quality, if it received a score between 8 to 11, 4 to 7 and 0 to 3, 
respectively (Rangel-Rincón et al. 2018). The degree of agreement between the two 
independent reviewers (VN and SP) and intra-examiner agreement in assessing the 
methodological quality of included systematic reviews was calculated by Cohen's kappa 
analysis.   
 
Results  
Literature search 
Relevant systematic reviews were identified and selected (Figure 1). The initial search 
resulted in 863 reviews and of these, 107 were removed as they were duplicates. Following 
title and abstract screening a total of 748 studies were excluded, because they did not satisfy 
the inclusion criteria with eight studies being shortlisted for full text retrieval. After reading 
the full text, three reviews were excluded for the following reasons: inclusion of studies with 
other anaesthetic solutions in the meta-analysis (Tupyota et al. 2018), inclusion of studies 
with a range of pulpal diagnoses and not limited to irreversible pulpitis (Katyal 2010, Bartlett 
et al. 2016). Finally, five systematic reviews with meta-analysis were included for the current 
umbrella review (Brandt et al. 2011, Kung et al. 2015, Su et al. 2016, St George et al. 2018, 
Nagendrababu et al. 2019).  
 
Characteristics of the included systematic reviews 
The general characteristics of the included systematic reviews with meta-analysis are 
summarized in Table 1. Figure 2 provides a summary of the meta-analyses for pulpal 
anaesthesia and adverse events, whereas Figure 3 provides the summary of the meta-
analyses for pain intensity during injection and onset time of pulpal anaesthesia.  Among the 
five included reviews, two were from the USA, with one each from the UK, China and 
Malaysia. The number of databases searched by the authors of the included reviews ranged 
from two to five and the reviews included between 3 and 15 randomised clinical trials. No 
other type of experimental clinical study was included in any review. Su et al. (2016) 
included amongst the 15 individual randomised clinical trials they analysed, four that 
included children under 16 years of age; all other reviews included only adults (>16 years).  
 
Three of the reviews used the Cochrane Collaboration Risk of Bias  tool for quality 
assessment (Kung et al. 2015, Su et al. 2016, St George et al. 2018), whereas one review used 
the more recently introduced Cochrane risk of bias tool (RoB 2.0) (Nagendrababu et al. 
2019).  Brandt et al. (2011) assessed the methodological quality of the trials they included 
within five domains, namely: randomization, allocation concealment, outcome assessment, 
adverse events reporting and loss to follow-up; as indicators of quality. All the systematic 
reviews were published in SCImago tier1/tier2 journals such as: International Endodontic 
Journal (Nagendrababu et al. 2019), Journal of Endodontics (Kung et al. 2015), Australian 
Endodontic Journal (Su et al. 2016) and Journal of the American Dental Association (Brandt et 
al. 2011). One review was published in the Cochrane database (St George et al. 2018).  
 
Heterogeneity and publication bias in the included systematic reviews 
Each systematic review used funnel plots to detect publication bias. The plots in two of the 
reviews were symmetrical and revealed no evidence of bias (Su et al. 2016, Nagendrababu 
et al. 2019), whereas the review by Kung et al. (2015) revealed asymmetry in the base of the 
funnel, indicative of potential publication bias. In the review by Brandt et al. (2011) 
publication bias was not assessed, with no reason being provided, while in the review by St 
George et al. (2018), publication bias was not assessed due to the small number of trials 
selected. In the meta-analyses of two studies (Kung et al. 2015, Su et al. 2016) comparing the 
anaesthetic efficacy of articaine with lidocaine including all delivery routes (combined with 
infiltration, mandibular blocks, supplemental infiltration), there was moderate 
heterogeneity (30-60% [Higgins & Green 2011]), whereas in the review by Brand et al. 
(2011) 0% heterogeneity was observed.  
 
Methodological quality 
A quality assessment of the five systematic reviews with meta-analysis included in this 
umbrella review is provided in Supplementary Table 1. The AMSTAR score for the included 
systematic reviews ranged from 8-11. Two reviews (Brandt et al. 2011, Kung et al. 2015) 
were scored as 0 for scientific quality of the included studies used appropriately in formulating conclusions . All the systematic reviews were categorized as high  quality.  The 
intra and inter-examiner reliability scores (VK and SP) for scoring the AMSTAR items of the 
included studies based on the Kappa statistics was 1 and 0.88 (p<0.001) respectively. This equates to almost perfect  agreement. 
 
Principal findings   
Five systematic reviews were finally included in this review, which contained 35 individual 
meta-analyses addressing four unique outcomes: 
1. Pulpal anaesthesia success rate from 31 meta-analyses; 
2. Pain intensity during injection from 1 meta-analysis; 
3. Onset time of pulpal anaesthesia from 1 meta-analyses;  
4. Adverse events from 1 meta-analysis.    
 
i. Pulpal anaesthesia 
Three reviews reported that articaine had a 1.15 – 2.3 times greater success rate than 
lidocaine (Kung et al. 2015, Su et al. 2016, St George et al. 2018), whereas Brant et al. (2011) 
concluded there was no difference between the solutions. Nagendrababu et al. (2019) 
included 8 clinical trials in their meta-analysis and concluded that articaine had a 1.16 times 
higher anaesthetic success rate than lidocaine, when the solutions were delivered as an 
IANB.  
 
Tooth and jaw: Generally, infiltrations are the preferred local anaesthetic technique for 
maxillary teeth with irreversible pulpitis. Three of the five reviews (Kung et al. 2015, Su et 
al. 2016, St George et al. 2018) performed a separate analysis for maxillary teeth. Among 
these, two reviews (Su et al. 2016, St George et al. 2018) concluded that articaine had a 
superior success rate than lidocaine, whereas another (Kung et al. 2015) concluded there 
was no difference between the two anaesthetic solutions for maxillary teeth. Four of the 
reviews performed analyses separately for mandibular teeth with irreversible pulpitis. They 
concluded that articaine had a greater anaesthetic success rate compared with lidocaine 
when the anaesthetic solution was delivered by any technique for anaesthetising mandibular 
molars. 
 
Technique: Three reviews (Kung et al. 2015, Su et al. 2016, St George et al. 2018) combined 
studies assessing the effectiveness of anaesthesia using various techniques of conventional 
IANB alone and conventional IANB supplemented by buccal infiltration. The other two 
reviews (Su et al. 2016, Nagendrababu et al. 2019) evaluated studies that used only IANBs.  
The analysis in these reviews revealed that articaine was superior to lidocaine for 
mandibular molars with irreversible pulpitis undergoing root canal treatment. 
 
Overall, four of the reviews concluded that articaine had a greater anaesthetic success rate 
than lidocaine during treatment of teeth with irreversible pulpitis.  
 
 
 
ii. Pain during injection 
Su et al. (2016) reported that articaine was associated with a lower pain (VAS) score during 
injection than lidocaine, however, this data was taken from only one clinical trial (Kanaa et 
al. 2012).  
 
iii. Onset of anaesthesia 
Su et al. (2016), taking into account the outcome of a meta-analyses from four pooled clinical 
trials, reported that articaine was associated with a more rapid onset of pulpal anaesthesia 
than lidocaine. 
 
iv. Adverse events 
Kung et al. (2015) highlighted that one trial they included reported the absence of adverse 
events, whereas no mention was made in the other studies they included. In contrast, Su et 
al. (2016) performed a meta-analysis for adverse events and reported that articaine was 
associated with a lower percentage of patients suffering adverse events than lidocaine, 
including oedema, haematoma, dizziness, nausea, allergy and shock. Thus, they concluded 
that articaine is less toxic and safer to use than to lidocaine (Su et al. 2016). None of the 
systematic reviews mentioned paraesthesia as an adverse event; however, this may not have 
been possible to identify and report since there was no long term follow-up of patients. 
 
Discussion 
The inability to achieve pulpal anaesthesia during root canal treatment has the potential to 
increase fear and anxiety in patients and thus make patient management more challenging, 
prolong the duration of appointments and create concerns in the mind of patients about the 
competence of the clinician. It may also exacerbate systemic medical conditions (Kung et al. 
2015). In an umbrella review, the results of multiple systematic reviews are compiled into a 
single overarching review, before synthesizing the data in an attempt to integrate all relevant 
information. The intention is to create greater clarity, reduce uncertainty for decision-
making, identify residual gaps in knowledge and provide a reference publication that 
contains the essential information on that topic. An umbrella review is considered to provide 
the highest level of scientific evidence, and thus the benchmark for clinical decision-making 
(Silva et al. 2012, 2015). Therefore, an umbrella review approach was used in this study to 
provide clear and unambiguous recommendations to clinicians when selecting articaine or 
lidocaine anaesthetic solutions for local anaesthesia of their adult patients presenting with 
irreversible pulpitis and requiring root canal treatment. The authors of the current umbrella 
review had planned to perform a meta-analysis, if the primary outcome of the five included 
reviews revealed a disagreement. However, the more recent systematic reviews (Kung et al. 
2015, Su et al. 2016, St George et al. 2018, Nagendrababu et al. 2019) all concluded that 
articaine was more effective than lidocaine, whereas Brant et al. (2011) reported no 
difference, probably due to the small number of clinical trials included. As a consequence of 
the consistent conclusions, it was considered that there was no need for a meta-analysis.  
 
Quality of systematic reviews 
The quality of the individual systematic reviews included in this umbrella review was categorised as high  when using the AMSTAR tool. AMSTAR has been reported to provide 
good evidence of validity and reliability, and helps the reader to appraise the critical 
components that a systematic review should include in order to appropriately interpret the 
results and its implications (Shea et al. 2007). AMSTAR has 11 domains namely: priori 
design, study selection and data extraction process, literature search, status of publication, 
studies list, characteristics of included studies, scientific quality of the included studies 
assessed and documented, scientific quality of the included studies used appropriately in 
formulating conclusions, methods to combine findings, publication bias and conflict of 
interest (Shea et al. 2007). A high AMSTAR score for a systematic review does not necessarily 
mean that the original randomised clinical trials they included were of high quality. 
However, carrying out a quality assessment of the individual randomised clinical trials 
included in a systematic review is important in order to evaluate the quality of evidence 
obtained by a subsequent meta-analysis. Two of the systematic reviews failed to formulate 
their conclusions based on the quality of the randomised trials they included (Brandt et al. 
2011, Kung et al. 2015).  This is a critical flaw of these reviews as it will affect the results and 
conclusions, which may be used subsequently to develop clinical practice guidelines that 
directly influence patient care.   
 
Strengths 
The current umbrella review was conducted with a robust methodology as it used three 
electronic databases to search for and identify suitable systematic reviews and two 
independent reviewers were involved in systematic review selection and data extraction. 
This rigorous methodology improves the quality of the review process.  The umbrella review 
only included systematic reviews that contained randomized clinical trials, to provide the 
highest level of evidence. Furthermore, a priori protocol registration in the PROSPERO 
database improves the methodological and reporting quality of a review, promoting 
transparency and reducing potential for bias, and helping to avoid unintended duplication 
of reviews.  
 
Limitations 
The heterogeneity among the randomized clinical trials included within each systematic 
review is by extension also a limitation of this umbrella review. Study heterogeneity included 
factors such as: geographic location, sample size, experience of operators, criteria for 
defining the diagnosis of symptomatic irreversible pulpitis, volume of anaesthetic solution, 
the concentration of vasoconstrictor and speed of injection. Systematic reviews published in 
language other than English were excluded, which creates a degree of selection bias. Among 
the five reviews, four included randomised clinical trials with only adult patients, whereas 
Su et al. (2016) included both children (<16 years) and adult patients.    
 
Flaws and inconsistencies at the primary research level further complicates the 
interpretation within this umbrella review, as the outcome measure used to assess the 
efficacy of local anaesthetic solutions in randomised clinical trials varied between studies. In 
some clinical trials, local anaesthetic efficacy was assessed by pulp sensibility testing (cold 
test/electric pulp tester) (Hsiao-Wu et al. 2007, Evans et al. 2008), while in others, efficacy 
was assessed by asking the patient to indicate discomfort/pain using a visual analogue scale 
(VAS) during access cavity preparation or pulp extirpation (Tortamano et al. 2009, Aggarwal 
et al. 2017). Nusstein et al. (1998) reported 42% of posterior teeth that had responded 
negatively to an electric pulp test, were associated with pain during root canal treatment. 
Thus, pulp sensibility testing is not a reliable indicator for assessing anaesthetic efficacy 
during actual treatment. The systematic review by Kung et al. (2015) combined clinical trials 
that assessed the outcome using pulp sensibility tests and patient pain ratings, whereas 
Nagendrababu et al. (2019) combined studies only using a patient rating scale or VAS. This 
variation in outcome measures creates uncertainty and confusion in the subsequent 
systematic review, with the result that clinicians are unsure of the best anaesthetic solution 
to use during root canal treatment of teeth with irreversible pulpitis.  
 
Reporting deficiencies and gaps in knowledge/methodology  
On reviewing the randomised clinical trials and systematic reviews on the topic of 
anaesthetic efficacy, several deficiencies in methodology and reporting were identified. To 
improve the quality of clinical trials and systematic reviews, the following recommendations 
are proposed on their conduct and reporting.  
 
Recommendations for conducting randomised clinical trials on anaesthetic solutions 
1. Adhere to CONSORT guidelines:  
The quality of evidence from this umbrella review is affected by the quality of the included 
systematic reviews and meta-analyses, as well as the quality of the individual randomised 
clinical trials included in each meta-analysis. For primary research studies, researchers must 
adhere to CONSORT guidelines and should register their clinical trial in advance in clinical 
trial registries such as ClinicalTrials.gov, Health Canada Clinical Trial Database, Iranian 
Registry of Clinical Trials, EU Clinical Trials Register, Australian New Zealand Clinical Trials 
Registry. 
 
2. Diagnosis – irreversible pulpitis:  
(i) Randomised clinical trials comparing the anaesthetic efficacy of various local anaesthetic 
solutions need to adhere to an accepted definition of irreversible pulpitis, for example the 
American Association of Endodontists (AAE 2013) defines irreversible pulpitis as Symptomatic irreversible pulpitis may include sharp pain upon thermal stimulus, lingering 
pain (often 30 seconds or longer after stimulus removal), spontaneity (unprovoked pain) 
and referred pain. Sometimes the pain may be accentuated by postural changes such as lying 
down or bending over and over-the-counter analgesics are typically ineffective . 
(ii) The presence or absence of an apical radiolucency/widening of the apical periodontal 
ligament should be included in the results.  If teeth exhibiting an apical radiolucency are to 
be excluded, this must be made explicit and a clear rationale provided. Details of the 
radiographic technique (e.g. films, exposure conditions, use of paralleling devices etc) and 
under what conditions the radiographs were interpreted must be included, e.g. the 
experience of each examiner and the degree of agreement (intrarater or interrater 
agreement) if two or more examiners were involved in the interpretation of radiographs.   
(iii) Details of the clinical process for establishing a pulpal diagnosis, as well as the 
techniques and devices used for pulp sensibility testing (manufacturer, city, country) must 
be described accurately.  
(iv) The experience of the operator(s) (undergraduate/postgraduate/endodontist) who 
performed the clinical examination, pulp sensibility tests and interpretation of radiographs 
to confirm the pulp status must be provided. The operator who performs the pulp sensibility 
tests should ideally be independent of the research team. Even with a clear definition of 
irreversible pulpitis and an independent evaluator of pulpal status, consistently diagnosing 
irreversible pulpitis can be difficult. Although, spontaneous, radiating pain that lingers after 
removal of the stimulus tends to indicate irreversible pulpitis (ESE 2019), it should be 
remembered that this is a dynamic clinical diagnosis, which does not always accurately 
reflect the histological inflammatory state of the pulp (Dummer et al. 1980). Indeed, 
irreversible pulpitis can be symptomless in anywhere between 14-60 % of cases (Seltzer et 
al. 1963, Michaelson & Holland 2002). This makes an accurate diagnosis of irreversible 
pulpitis difficult and often unreliable even for experienced operators, which adds a potential 
bias into a clinical trial.  
 
3. Inclusion/exclusion criteria:  
The selection criteria of patients/volunteers must be described clearly. The age of the 
patients, preoperative pain status and how it was measured, radiographic status and medical 
and dental history (such as history of trauma, previous restorative and orthodontic 
treatments, previous pain from the tooth) are essential.  Patients taking medication that 
could interfere with the action of any of the anaesthetic solutions must be excluded and 
reasons for their exclusion highlighted in the results section. 
 
4. Anaesthetic solution:   
Details of the anaesthetic solutions must be provided including: volume, concentration, 
vasoconstrictor used, and temperature when injected. 
 
5. Delivery of anaesthetic solution:   
The length and gauge of the needle used to deliver the anaesthetic solution(s) must be 
provided as well as the estimated average injection speed. 
 
6. Blinding:  
The blinding method and individuals involved in the blinding process must be described fully 
including operator, patient and evaluator. 
 
7. Time before intervention:  
The period between delivery of an anaesthetic solution and the assessment of anaesthetic 
efficacy must be standardised and reported (e.g. lip numbness, patient self-reported 
assessment [Visual Aanalog Scale]). 
 
8. Outcome measure:  
In teeth with irreversible pulpitis, the lack of a response to pulp sensibility tests might not 
guarantee profound pulpal anaesthesia for painless treatment. The waiting time between 
sensibility tests may also have an effect with evidence that the result of the first test may 
have an effect on the reaction to subsequent tests to give a false negative result (Nusstein et 
al. 2010). Hence, a more reliable indicator for assessing anaesthetic efficacy in clinical trials 
is to record pain during the endodontic procedure (e.g. access cavity preparation, pulp tissue 
manipulation, canal instrumentation). It would be best practice to report the success of 
anaesthesia separately for access cavity preparation, initial pulp penetration and canal 
instrumentation procedures (Poorni et al. 2011). Details of the individual(s) who performed 
the root canal treatment procedure(s) must be described, for example, were they blinded to 
the experimental groups, how many operators were involved, their status 
(undergraduate/postgraduate/endodontist) and their relative experience. 
 
9. Clinical significance of the results:  
When planning randomised clinical trials comparing two local anaesthetic solutions, it is 
critical that the study be adequately powered. Several randomised clinical trials that have 
compared articaine with lidocaine in teeth with irreversible pulpitis and used a VAS to 
measure pain during root canal instrumentation, have reported a trend for more effective 
anaesthesia, albeit non-significant, results with articaine (Poorni et al. 2011, Sood et al. 2014, 
Allegretti et al. 2016). For example, Sood et al. (2014) reported 88% success with articaine 
and 82% success with lidocaine, while Poorni et al. (2011) reported 69% with articaine and 
65% with lidocaine, and Allegretti et al. (2016) 63.6% for articaine and 54.5% for lidocaine. 
In addition to the lack of statistical significance, the number of participants was also 
relatively small (<55 patients in each arm) increasing the potential for type II error as the 
studies were underpowered. It is essential that new studies investigating articaine and 
lidocaine use previously published percentage differences to establish the sample size.  
 
10. Adverse event:  
The occurrence of adverse event(s) during clinical trials and how they are managed must be 
carefully described.  If no adverse event(s) occur this should also be mentioned.  
 
Recommendations for conducting systematic reviews and meta-analyses on anaesthetic 
solutions 
The quality of evidence from this umbrella review is affected by the methodological and 
reporting quality of the included systematic reviews and meta-analyses. All systematic 
reviews and meta-analyses must adhere to the AMSTAR and PRISMA guidelines and 
additionally authors need to consider the following parameters, while conducting and 
reporting systematic reviews and meta-analyses on local anaesthetic solutions:  
i. The results of the scientific quality assessment (risk of bias) of the primary randomised 
trials they include and use that information to formulate the conclusions;  
ii. Sub-group and sensitivity analysis based on outcome measures (pulp sensibility, record 
pain during the endodontic procedure), and local anaesthetic solution (volume, 
concentration, vasoconstrictor used, and temperature);  
iii. Evaluation of adverse events associated with commonly used local anaesthetic solutions;  
iv. A clear and consistently applied definition of pulpal status must be used. 
 
These recommendations will help to increase the accuracy, validity and credibility of 
publications through the development of high-quality manuscripts. They will also help 
researchers to effectively plan and design randomised clinical studies and systematic 
reviews for the benefit of clinicians and patients.  
 
Concluding remarks 
This umbrella review collated evidence from existing systematic reviews and draws the 
following conclusions: 
i. There is sufficient evidence to conclude that articaine is associated with greater local 
anaesthetic success rates than lidocaine following IANBs, infiltrations and supplemental 
injections during root canal treatment of teeth with irreversible pulpitis; 
ii. There is limited evidence to suggest that the injection of articaine is less painful than the 
injection of lidocaine in patients with irreversible pulpitis undergoing root canal treatment; 
iii. There is limited evidence to suggest that articaine is associated with a more rapid onset 
of pulpal local anaesthesia than lidocaine in teeth with irreversible pulpitis undergoing root 
canal treatment;  
iv. There is limited evidence to suggest that articaine local anaesthetic injections are 
associated with fewer adverse events than lidocaine; 
v. Numerous reporting deficiencies and gaps in knowledge have been identified.  
It is hoped that these recommendations will help researchers to effectively plan and design 
randomised clinical trials and systematic reviews for the benefit of clinicians and patients 
and also help to increase the accuracy, validity and credibility of publications through the 
development of high-quality manuscripts.  
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Figure 1: Search process. 
Figure 2: Meta-analyses summary for pulpal anaesthesia and adverse events outcomes. Note: 
CI- Confidence Interval, MD- Mean difference, NR- Not reported, NA- Not applicable, RR- Risk 
Ratio, OR- Odds Ratio, 
Figure 3: Meta-analyses summary for pain intensity during injection and onset time of pulpal 
anaesthesia. Note: CI- Confidence Interval, MD- Mean difference, NR- Not reported, NA- Not 
applicable, RR- Risk Ratio, OR- Odds Ratio, 
  
 
Table 1: Main characteristics of the included systematic reviews and meta-analysis 
S 
No  
Author, year Name of the 
journal 
published 
Database 
searched 
Country 
of the 
first 
author 
Search 
Period 
Language Groups Number 
of 
studies 
included 
for 
meta-
analysis 
Study 
design – 
included 
studies 
Instrument of 
quality 
Assessment 
1 Brandt et al. 
2011 
Journal of 
American 
Dental 
Association  
MEDLINE and 
Embase 
USA 1970 to 
2009 
English, 
German, 
Croatian 
and 
Russian 
4% Articaine, 
2% Lidocaine in 
combination 
with 
vasoconstrictor 
3 Randomis
ed clinical 
trials  
Five domains 
namely: 
randomization, 
allocation 
concealment, 
outcome 
assessment, 
adverse effect 
reporting and 
loss to follow-up 
2.  Kung et al. 
2015 
Journal of 
Endodontics 
MEDLINE, 
Scopus and 
Cochrane 
Library  
USA 1976  
to 2013 
No 
language 
restriction. 
(if an 
abstract 
was not 
available 
in English 
for 
screening 
purposes, 
the article 
was not 
included) 
4% Articaine, 
2% Lidocaine in 
combination 
with 
vasoconstrictor  
10 Randomis
ed clinical 
trials  
Cochrane 
Collaboration  
3 Su et al. 2016 Australian 
Endodontic 
Journal 
MEDLINE, 
Cochrane 
Central 
Register of 
Controlled 
Trials, 
EMBASE, 
China 1946 to 
2015 
No 
language 
restriction 
4% Articaine, 
2% Lidocaine in 
combination 
with 
vasoconstrictor 
15 Randomis
ed clinical 
trials  
Cochrane 
Collaboration Risk of Bias  tool 
Chinese 
BioMedical 
Literature 
Database and 
China 
National 
Knowledge 
Infrastructure  
4 St George et al. 
2018 
Cochrane 
Database of 
Systematic 
Reviews 
Cochrane 
Central 
Register of 
Controlled 
Trials 
(CENTRAL; 
the Cochrane 
Library; 2018, 
Issue 1), 
MEDLINE 
(OVID SP), 
Embase, 
CINAHL PLUS, 
WEB OF 
SCIENCE, 
UK Until 
2018 
No 
language 
restriction 
4% Articaine, 
2% Lidocaine in 
combination 
with 
vasoconstrictor 
4 Randomis
ed clinical 
trials  
Cochrane 
Collaboration Risk of Bias  tool 
5 Nagendrababu 
et al. 2019 
International 
Endodontic 
Journal 
PubMed, 
Scopus 
Malaysia Inception 
to 2018 
English 4% Articaine, 
2% Lidocaine in 
combination 
with 
vasoconstrictor 
15 Randomis
ed clinical 
trials  
Cochrane risk of 
bias (RoB 2.0) 
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